Evolution of the Average Target: Galderma Group AG

Evolution of the Target Price: Galderma Group AG

Changes in Analyst Recommendations: Galderma Group AG

29ade1fd67467.zFF05G_ZqnQRkAnx4rFzmBbrz61-5UjNVkL9pqDTBUA.lCAT1V-U_ABfo2eou-A40EOHp84_iDKVGiul6pW0MXOmBRjQN5r5BV31RA~e517cccbcd523668ce4bb71d9da554af
May. 11 Galderma Group's Maiden Capital Markets Day to Target Funds Allocation, Berenberg Says MT
Apr. 27 Galderma One of Berenberg's 2026 Top Picks Amid 'Strong Set' of Q1 Results MT
Apr. 17 RBC Keeps Galderma at Sector Perform Rating Ahead of Q1 Results, Says Growth Momentum Already Priced In MT
Apr. 01 Galderma Price Target Up as Berenberg Notes 'Increased Confidence' in Growth Potential MT
Apr. 01 BofA Forecasts Galderma Q1 Sales Growth on Nemluvio Launch Benefits, Injectable Aesthetics Boost MT
Mar. 26 CITIC Securities Kicks off Galderma Group Coverage with Buy Rating MT
Mar. 23 Octavian Starts Galderma Coverage with Buy Rating MT
Mar. 20 Oddo BHF Starts Galderma with Outperform Rating MT
Mar. 09 Galderma Price Objective Lifted as BofA Notes Better-than-expected FY25 Results, FY26 Guidance MT
Mar. 03 HC Wainwright Kicks off Galderma Group Coverage at Buy MT
Jan. 13 Deutsche Bank Kicks off Galderma Group Coverage at Hold MT
Jan. 09 L'Oréal, Top Gainer on the CAC 40 and SRD at Midday Friday, January 9, 2026 Zonebourse
Dec. 17 BofA Expects Sustained Momentum for Galderma in FY26; Price Objective, Estimates Raised MT
Dec. 12 Swiss stocks - Factors to watch on December 12 RE
Dec. 09 BofA Reaffirms L'Oréal's Buy Rating After Galderma Stake Boost MT
Dec. 08 Swiss stocks - Factors to watch on December 8 RE
Nov. 05 Swiss stocks - Factors to watch on November 5 RE
25-10-30 RBC Ups Galderma Group Price Target, Estimates After Q3 Results, FY25 Guidance Lift MT
25-10-30 Berenberg Lifts Galderma Group Price Target, Estimates on FY25 Guidance Raise MT
25-10-29 Swiss stocks - Factors to watch on October 29 RE
25-10-27 Block trade Galderma secondary ABB orders below CHF 130 per share, risk missing says bookrunner RE
25-10-27 Galderma secondary ABB's books covered, says bookrunner RE
25-10-27 BofA Lifts Galderma's Price Target, Estimates After 'Impressive' Q3 Sales Beat MT
25-10-20 Berenberg Raises Galderma Group Price Target on Product Launch Potential MT
25-10-17 Swiss stocks - Factors to watch on October 17 RE

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.34%
+13.73%
+24.52%
+10.89%
+42.41%
+61.97%
+63.08%
+26.74%
+15.5%
+4.26%
Average +28.04%
Weighted average by Cap. +16.34%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
199.11USD
Average target price
233.64USD
Spread / Average Target
+17.34%
High Price Target
330.77USD
Spread / Highest target
+66.13%
Low Price Target
144.20USD
Spread / Lowest Target
-27.58%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Citic Securities
Octavian AG
ODDO BHF
HC Wainwright
Deutsche Bank Research
William O'Neil & Co.
RBC Capital Markets
JPMorgan
Bank Vontobel AG
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
199.11USD
Average target price
233.64USD
Spread / Average Target
+17.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GALD Stock
  4. Consensus Galderma Group AG